Pharmacy benefit management startup Capital Rx earned $3.5 billion in revenue last year as Congress sought to reign in the legacy middlemen that have long profited from high drug costs. Pharmacy ...

As healthcare costs rise, prescription drugs can be one of the costliest aspects of the healthcare experience. In an interview, RxSaveCard CEO and Founder Chris Crawford talked about his new ...

Your local pharmacy might be the next front in Donald Trump’s trade war. The president has in recent weeks promised to impose tariffs on all foreign-made medications, a move intended to ...

Trump rescinded Executive Order 14087, "Lowering Prescription Drug Costs for Americans," which directed Medicare and Medicaid agencies to research and implement models for lowering the costs of ...

which means that for Medicare beneficiaries it must be covered by insurers and pharmacy benefit managers. For such medications, rebates and discounts are relatively small as payers have little ...

DAYTON, Ohio (WDTN) — One long-time local pharmacy is weighing in on President Trump’s decision to rescind the Biden administration’s plan to lower prescription drug costs. This was just one ...

Steve Edmunds from Alliance Insurance Company and Catherine Sevier from AARP join us to talk about how prescription drug coverage has changed for Medicare in 2025. This is something that's brand ...

WEST PALM BEACH, Fla. — WPTV is looking into the cost of some prescription drugs after an executive order issued Monday by President Donald Trump. Trump's executive order rescinded a 2022 ...

The majority of Americans think prescription drug costs are unreasonable and believe a major contributor to the high cost is profits made by pharmaceutical companies, a survey by KFF found.

Languages: English. President Donald Trump has been accused of raising prescription drug prices for seniors by immediately rescinding former President Joe Biden's executive order to lower costs ...

In October 2022, former President Biden directed the Center for Medicare and Medicaid Innovation (CMMI) to develop payment models intended to lower prescription drug costs. The models are ...

Biosimilars are the commonsense, bipartisan solution to out-of-control prescription drug prices. In the last 10 years, biosimilars have been associated with savings of $56 billion compared to what ...